Of note, ex vivo work-up revealed a large variety of solid cancers and hematological malignancies, which upregulate CXCR4 on the tumor cell surface, thereby rendering this G-protein coupled receptor as an attractive target for imaging and treatment [1]. This evidence concerns the gene CXCR4 and hematologic disorder.